Eleven patients with osteoarthritis and mild hypertension completed an 8-week, double-blind crossover study in which 200 mg tiaprofenic acid 3-times daily or placebo were substituted for their normal non-steroidal anti-inflammatory therapy. Systolic blood pressure was significantly higher on tiaprofenic acid therapy than on placebo and plasma renin activity was significantly lower on active treatment. No significant changes were seen in biochemical parameters, though the weight of the patient was also higher on tiaprofenic acid than on placebo. Duration of morning stiffness was also lower on tiaprofenic acid than on placebo. Blood pressure on tiaprofenic acid was not different from baseline readings on other non-steroidal antiinflammatory drug therapy. This study suggests that tiaprofenic acid, like other nonsteroidal anti-inflammatory agents, may interfere with blood pressure control in treated hypertensive patients.
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I n t r o d u c t i o n
Tiaprofenic acid is a new non-steroidal anti-inflammatory drug which has significant anti-inflammatory and analgesic effects in animal models of inflammation.
5
Pharmacokinetic studies demonstrate rapid absorption from the gastro-intestinal tract with a relatively short plasma elimination half-life of about 2 hours. 
